A case of anti-NMDAR (N-methyl-D-aspartate receptor) encephalitis: A rehabilitation perspective

NeuroRehabilitation

Volumn 30, Issue 2, 2012, Pages 109-112

  Tham, Shuen Loong ^a   Kong, Keng He ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Anti NMDAR encephalitis; autoimmune; N Methyl D Aspartate Receptor; paraneoplastic; rehabilitation

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; ETIRACETAM; IMMUNOGLOBULIN; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENYTOIN; RITUXIMAB; TRIHEXYPHENIDYL; VALPROIC ACID;

ADOLESCENT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTICONVULSANT THERAPY; APHASIA; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; COGNITIVE DEFECT; CONFUSION; CONSCIOUSNESS DISORDER; CONVALESCENCE; DISEASE SEVERITY; DISORIENTATION; DIZZINESS; ELECTROENCEPHALOGRAPHY; FEMALE; HEAD INJURY; HUMAN; LABORATORY TEST; MOTOR DYSFUNCTION; MULTIPLE CYCLE TREATMENT; MUSCLE RIGIDITY; NEUROIMAGING; NEUROLOGIC EXAMINATION; OCCUPATIONAL THERAPY; OROFACIAL DYSKINESIA; PHYSIOTHERAPY; REHABILITATION CENTER; SEIZURE; SPEECH THERAPY; TREATMENT OUTCOME;

ADOLESCENT; ANTIBODIES; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; FEMALE; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84859321065     PISSN: 10538135     EISSN: 18786448     Source Type: Journal    
DOI: 10.3233/NRE-2012-0733     Document Type: Article

References (8)

1. Breese EH, Dalmau J, Lennon VA, Apiwattanakul M, Sokol DK (2010). Anti-N-Methyl-S-Aspartate Receptor Encephalitis: Early treatment is beneficial. Pediatric Neurology, 42, 213-214.
2. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008). Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology, 7, 1091-1098.
3. Dalmau J, Lancaster E,Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011). Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurology Jan, 10(1), 63-74.
4. Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner L, Collins A, Dengel A, Dalmau J (2009). Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. European Journal of Clinical Microbiology and Infectious Diseases, 28, 1421-1429.
5. Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008). Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal. Neurology, February 12, 70(7), 504-511.
6. Iizuka T, Yoshii S, Kan S, Hamada J, Dalmau J, Sakai F, Mochizuki H (2010). Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. Journal of Neurology, Oct, 257 (10), 1686-1691. Epub 2010 Jun 2.
7. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien, CG, Vincent A (2010). N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain, 133, 1655-1667.
8. Ishiura H, Matsuda S, Higashihara M, Hasegawa M, Hida A, Hanajima R,Yamamoto T, Shimizu J, Dalmau J, Tsuji S (2008). Response of anti-NMSA receptor encephalitis without tumor to immunotherapy including rituximab. Neurology, 71, 1921-1923.